Resisting the Resistance: Experts versus Superbugs - European Medical Journal

Resisting the Resistance: Experts versus Superbugs

This podcast series has been sponsored by bioMérieux. The views and opinions expressed in this podcast are those of the individual speakers and do not necessarily reflect those of bioMérieux or EMJ.


In this three-part podcast series “Resisting the Resistance: Experts versus Superbugs,” host Hannah Moir leads a roundtable discussion with experts Luke Moore, Timothy Rawson, and Derek Cocker.

They outline the current state of the fight against antimicrobial resistance (AMR), discussing the latest developments in prevention strategies, and the need for sustainable access to effective antibiotics. The series sheds light on how these factors may impact our battle against AMR and offers valuable insights from the experts as they explore the potential for a new era in the fight against superbugs.

Episode 1: The Threat of Superbugs and the Global Fight Against AMR

Our experts consider the most recent global data on the forecast of AMR, the factors propelling the battle against resistance, and the impact on public health. They discuss the immediate challenges and emphasise the urgency of the problem.

Spotify | Apple | Amazon MusicDownload MP3 (21:45 mins)

 

Episode 2: Antimicrobial Stewardship and Diagnostics Tools for Frontline Healthcare

Our experts discuss the key concepts to supporting the frontline fight against AMR through the importance of antimicrobial stewardship practices, sustainable access to effective antibiotics, and the role of diagnostic tools in supporting these efforts.

Spotify | Apple | Amazon MusicDownload MP3 (22:43 mins)

 

Episode 3: Innovations and the Future of AMR through Sustainable Access and Global Collaboration

Our experts discuss the necessity of global access to antibiotics and the role that key stakeholders play in paving the way for future solutions to address the issue of AMR. They provide insights into the pathways towards a sustainable future.

Spotify | Apple | Amazon MusicDownload MP3 (24:10 mins)

 

Speakers:

Luke Moore1

 

Timothy Rawson2

 

Derek Cocker3

 

1. Infectious Diseases Physician and Clinical Microbiologist, Chelsea and Westminster Hospital, Honorary Clinical Senior Lecturer, Department of Infectious Disease, Faculty of Medicine, Imperial College London, UK
2. Infectious Diseases and Medical Microbiology specialist trainee, Imperial College Healthcare NHS Trust, Honorary Clinical Lecturer, Department of Infectious Disease, Faculty of Medicine, Imperial College London, UK.
3. Academic Clinical Lecturer in Infectious Diseases and Global Health in the David Price Evans Infectious Diseases & Global Health Research Group, part of the Faculty of Health and Life Sciences at the University of Liverpool, UK where his current work focuses on evaluating the One Heath drivers of antimicrobial resistance.

Moderator

Hannah Moir1

 

1. Head Medical Writer, Moderator, and Educator, EMJ, London, UK. Senior Fellow (Associate Professor in Health & Exercise Prescription), Faculty of Health, Science, Social Care and Education, Kingston University, London, UK.

References

1. The Lancet Series on Antimicrobial Resistance: The need for sustainable access to effective antibiotics. May 2024. Available at: https://www.thelancet.com/series/antibiotic-resistance?dgcid=tlcom_infographic_amr2024_lancet. Last accessed: 15 October 2024.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.